Replies to post #212229 on Biotech Values

[biomaven0]

>>Keytruda in lung cancer may not be as good as we think

Or it could be better...

[jq1234]

If the authors have any integrity after stating no more mature data from Keynote-024, they should publish another article to set the record straight after MRK presented more mature data with median 19 months follow-up from previous 11 months, confirmed OS Keytruda benefit even after more patients from chemo arm crossed over to Keytruda at ASCO2017:

https://twitter.com/jq1234t/status/881567583966818304